Dendreon (DNDN) May volatility elevated at 99 into data
Dendreon (Nasdaq: DNDN) closed at $29.31. DNDN's provenge (a drug that prolongs the lives of advanced prostate-cancer patients) has a PDUFA this spring. DNDN December option implied is at 70, February is at 74, May is at 99; verses its six-month average of 75, according to Track Data. Paul Foster
You May Also Be Interested In
- UPDATE: Jefferies Starts Dendreon (DNDN) at Underperform, Sees 35% Downside
- Cree (CREE) Volatility Elevated as Shares Dive on CFO Resgination
- Urban Outfitters (URBN) Volatility Lower into Q1 Results
Create E-mail Alert Related Categories
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
